Rezlidhia (olutasidenib capsules)

Rezlidhia (olutasidenib) is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible DH1 mutation as detected by an FDA-approved test.

Olysio (simeprevir hard gelatin capsules)

Olysio (simeprevir) is a protease inhibitor used to treat chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.

Synribo (omacetaxine mepesuccinate)

Synribo (omacetaxine mepesuccinate) is a tyrosine kinase inhibitor (TKI) used to treat adults with chronic myelogenous leukemia (CML).

Xolair (omalizumab)

Xolair (omalizumab) is an antibody that helps decrease allergic responses in the body used to treat moderate to severe asthma that is caused by allergies in adults and children who are at least 12 years old. Xolair is usually given after other asthma medications have been tried without successful treatment of symptoms.

Skyclarys (omaveloxolone capsules, for oral use)

Technivie (ombitasvir, paritaprevir and ritonavir tablets)

Technivie (ombitasvir, paritaprevir, and ritonavir) is a fixed-dose combination of a hepatitis C virus NS5A inhibitor, a hepatitis C virus NS3/4A protease inhibitor, and a CYP3A inhibitor, and is indicated in combination with ribavirin for the treatment of patients with genotype 4 chronic hepatitis C virus (HCV) infection without cirrhosis.

Viekira Pak (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets)

Viekira Pak (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir) is a fixed dose combination tablet that includes a hepatitis C virus NS5A inhibitor, a hepatitis C virus NS3/4A protease inhibitor, and a CYP3A inhibitor that inhibits CYP3A mediated metabolism of paritaprevir. Dasabuvir is a hepatitis C virus nonnucleoside NS5B palm polymerase inhibitor, which is supplied as separate tablets in the copackage. Taken with or without ribavirin, it is used for the treatment of patients with genotype 1 chronic hepatitis C virus (HCV) infection including those with compensated cirrhosis.

Omeclamox-Pak (omeprazole delayed-release capsules)

Omeclamox-Pak (omeprazole delayed-release capsules 20 mg, clarithromycin tablets 500 mg, and amoxicillin capsules 500 mg) is a combination of a proton pump inhibitor (PPI), a macrolide antimicrobial, and a penicillin antibiotic, indicated for the treatment of patients with Helicobacter pylori infection and duodenal ulcer disease (active or up to one-year history) to eradicate H. pylori.

Omtryg (omega-3-acid ethyl esters a capsules)

Omtryg (omega-3-acid ethyl esters A) is a lipid-regulating agent used as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia.

Prilosec (omeprazole)

Prilosec (omeprazole) is a proton pump inhibitor (PPI) used for the treatment of conditions such as ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome, which are all caused by stomach acid. Prilosec is available in generic form.